CABG | Valvular | P | |
---|---|---|---|
Number | 51 | 49 | - |
Age | 64.65 ± 13.34 | 72.7 ± 10.4 | 0.106¶ |
Sex (Women, %) | 8 (15.69%) | 22 (44.89%) | 0.001* |
BMI (kg/m2) | 26.91 ± 0.43 | 26.51 ± 0.57 | 0.5726§ |
EF (%) | 62.51 ± 1.84 | 69.2 ± 1.41 | 0.006§ |
Tobacco | 12 (23.53%) | 9 (18.37%) | 0.698* |
Alcohol intake | 15 (29.41%) | 14 (28.57%) | 0.898* |
Hypertension | 31 (60.78%) | 27 (55.10%) | 0.486* |
Dyslipidemia | 31 (60.78%) | 16 (32.65%) | 0.003* |
Diabetes | 24 (47.06%) | 5 (10.20%) | < 0.001* |
ACEI/ARB | 25 (49.02%) | 19 (38.77%) | 0.302* |
Beta blockers | 16 (31.37%) | 9 (18.37%) | 0.133* |
Calcium blockers | 8 (15.69%) | 10 (20.41%) | 0.539* |
Antiplatelet drugs | 33 (64.71%) | 8 (16.33%) | < 0.001* |
Statins | 34 (66.67%) | 11 (22.45%) | < 0.001* |
Nitrates | 16 (31.37%) | 2 (4.08%) | < 0.001* |
Oral antidiabetics | 16 (31.37%) | 2 (4.08%) | < 0.001* |
Insulin | 13 (25.49%) | 1 (2.04%) | < 0.001* |
MI < 30 days | 16 (31.37%) | 0 (0%) | < 0.001* |
EuroSCORE | 3.6 ± 0.4194 | 5.7 ± 0.4 | < 0.001* |